blood flow increased ( 220 or 130 % of control ) with the serosal application of 10 ( -6 ) m n-ethyl carboxamido adenosine ( neca , a2-selective agonist ) or 2-chloro adenosine ( 2ca , nonselective agonist ) but not with cyclohexyl adenosine ( cha , a1-selective agonist ) .
C0050789
neca
C0001443
adenosine